A
37
-2
CFG
74
2
DRI
50
-3
MCHP
34
-2
CAG
24
-3
WDC
37
-3
IRM
41
3
XOM
42
-6
TXT
53
-3
TDC
67
-4
CSX
57
-4
CMI
64
-3
WHR
65
-5
KMX
61
-3
URI
60
-6
D
40
2
TMO
42
-6
CMG
66
-4
ROST
57
-3
DGX
48
11
A
37
-2
CFG
74
2
DRI
50
-3
MCHP
34
-2
CAG
24
-3
WDC
37
-3
IRM
41
3
XOM
42
-6
TXT
53
-3
TDC
67
-4
CSX
57
-4
CMI
64
-3
WHR
65
-5
KMX
61
-3
URI
60
-6
D
40
2
TMO
42
-6
CMG
66
-4
ROST
57
-3
DGX
48
11
Financhill
Back

GAMCO Global Gold Natural Resources & Income Trust Vs. Halozyme Therapeutics Industry Stock Comparison

Sell
39

GGN
GAMCO Global Gold Natural Resources & Income Trust

Last Price:
4.05
Seasonality Move:
2.01%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
45.65
Seasonality Move:
17.03%
Sell
39
GAMCO Global Gold Natural Resources & Income Trust (GGN) is a Sell

Is GAMCO Global Gold Natural Resources & Income Trust a Buy, Sell or Hold?

  • The current GAMCO Global Gold Natural Resources & Income Trust [GGN] share price is $4.05. The Score for GGN is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • GGN is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

GGN Stock Price Chart

What is GAMCO Global Gold Natural Resources & Income Trust's stock price today?

  • The GAMCO Global Gold Natural Resources & Income Trust share price today is $4.05
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GGN is experiencing selling pressure, which indicates risk of future bearish movement.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

GGN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.06 Sell
Relative Strength Index (14 RSI): 23.99 Sell
Chaikin Money Flow: -428466 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (4.22 - 4.46) Sell
Bollinger Bands (100): (4.08 - 4.34) Sell

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

GGN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 4.21 Sell
20-day SMA: 4.33 Sell
50-day SMA: 4.31 Sell
200-day SMA: 4.08 Sell
8-day EMA: 4.18 Sell
20-day EMA: 4.27 Sell
50-day EMA: 4.28 Sell
200-day EMA: 4.1 Sell

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

GAMCO Global Gold Natural Resources & Income Trust Earnings Growth & GGN Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.30 per share, and an increase next year of $0.71 per share.

GAMCO Global Gold Natural Resources & Income Trust Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):